ATE237140T1 - Icam-4 und dessen diagnostische verwendungen - Google Patents

Icam-4 und dessen diagnostische verwendungen

Info

Publication number
ATE237140T1
ATE237140T1 AT98953249T AT98953249T ATE237140T1 AT E237140 T1 ATE237140 T1 AT E237140T1 AT 98953249 T AT98953249 T AT 98953249T AT 98953249 T AT98953249 T AT 98953249T AT E237140 T1 ATE237140 T1 AT E237140T1
Authority
AT
Austria
Prior art keywords
icam
diagnostic uses
quantitating
association
concentration
Prior art date
Application number
AT98953249T
Other languages
English (en)
Inventor
Patrick D Kilgannon
W Michael Gallatin
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Priority claimed from PCT/US1998/020876 external-priority patent/WO1999018441A1/en
Application granted granted Critical
Publication of ATE237140T1 publication Critical patent/ATE237140T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70525ICAM molecules, e.g. CD50, CD54, CD102
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Credit Cards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Hall/Mr Elements (AREA)
  • Air Bags (AREA)
  • Escalators And Moving Walkways (AREA)
AT98953249T 1997-10-02 1998-10-02 Icam-4 und dessen diagnostische verwendungen ATE237140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94286797A 1997-10-02 1997-10-02
PCT/US1998/020876 WO1999018441A1 (en) 1992-01-27 1998-10-02 Icam-4 and diagnostic uses thereof

Publications (1)

Publication Number Publication Date
ATE237140T1 true ATE237140T1 (de) 2003-04-15

Family

ID=25478728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953249T ATE237140T1 (de) 1997-10-02 1998-10-02 Icam-4 und dessen diagnostische verwendungen

Country Status (13)

Country Link
EP (2) EP0956508B1 (de)
JP (1) JP2001508181A (de)
CN (1) CN1132014C (de)
AT (1) ATE237140T1 (de)
AU (1) AU735917B2 (de)
BR (1) BR9806294A (de)
CA (1) CA2273195A1 (de)
DE (1) DE69813181T2 (de)
DK (1) DK0956508T3 (de)
ES (1) ES2201547T3 (de)
IL (1) IL130228A0 (de)
NO (1) NO992666L (de)
RU (1) RU2208230C2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2228708C1 (ru) * 2002-12-18 2004-05-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ дифференциальной диагностики типа деменции
RU2281506C1 (ru) * 2005-01-31 2006-08-10 ГОУ ВПО Смоленская государственная медицинская академия Министерства здравоохранения Российской Федерации Способ диагностики минимальных дисфункций мозга у детей
EP4465051A3 (de) * 2018-05-29 2025-01-22 Cognizance Biomarkers, Inc. Biomarker und verfahren zur beurteilung und behandlung von epileptischen vs nichtepileptischen anfällen / keine anfälle / psychogene nichtepileptische anfälle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO900155L (no) * 1989-01-24 1990-07-25 Molecular Therapeutics Inc Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1.
CN1188528C (zh) * 1991-06-11 2005-02-09 血液研究中心 细胞间粘附分子-3及其配体
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4

Also Published As

Publication number Publication date
ES2201547T3 (es) 2004-03-16
CA2273195A1 (en) 1999-04-15
RU2208230C2 (ru) 2003-07-10
CN1132014C (zh) 2003-12-24
DE69813181T2 (de) 2004-03-04
EP1338896A3 (de) 2004-01-02
IL130228A0 (en) 2000-06-01
BR9806294A (pt) 2001-09-25
EP0956508B1 (de) 2003-04-09
EP1338896A2 (de) 2003-08-27
NO992666D0 (no) 1999-06-02
EP0956508A1 (de) 1999-11-17
NO992666L (no) 1999-08-02
CN1246923A (zh) 2000-03-08
DK0956508T3 (da) 2003-08-04
AU1066999A (en) 1999-04-27
JP2001508181A (ja) 2001-06-19
DE69813181D1 (de) 2003-05-15
AU735917B2 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU3142597A (en) Dha-pharmaceutical agent conjugates
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
ATE273301T1 (de) Substituierte aza- und diazacycloheptan- und - cyclooctanverbindungen und deren verwendung
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
DE69408032D1 (de) Vorrichtung zur Verminderung des Laufgeräusches von Fahrzeugen
DE69527801D1 (de) Ultrahochfeste stähle und verfahren zu deren herstellung
DE69503711D1 (de) Strassen- oder Schienenfahrzeug und dessen Montageverfahren
DE3584174D1 (de) Rheumamittel.
DE69710136D1 (de) Schnelle kontinuierliche Messmethode des biochemischen Sauerstoffbedarfes (BOD) und Vorrichtung dafür
ATA66594A (de) Mittel zur ad- und absorption von fluiden
ATE181549T1 (de) Verfahren zur herstellung von (s)-3-amino-1- substituiert-pirrolidine
ATE237140T1 (de) Icam-4 und dessen diagnostische verwendungen
DE69633115D1 (de) Stromquelle und verfahren zum induktionserwärmen von gegenstanden
DE59511030D1 (de) Verfahren und Teilreagenz zur Bestimmung von Eisen in Serum
DE59607114D1 (de) Avivagemittel
DE59700064D1 (de) Homogenisierung von Dispersionen
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
FI953601A7 (fi) Menetelmä ja laite jäteveden käsittelemiseksi biologisella aktivoinnilla
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel
DE69626354D1 (de) Am sekundären Kohlenstoffatom markiertes Acyl-L-Carnitin und diagnostische Mittel es enthaltend
ATE97811T1 (de) Antipsychotisch wirksames imidazobenzodiazepin.
ATE186731T1 (de) Anomere fluorribosylamine
DE69319127D1 (de) Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
DE59509369D1 (de) Verfahren zur gewinnung von peptidamidase enthaltenden mikroorganismen, damit gewonnene mikroorganismen, darin enthaltene peptidamidasen und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0956508

Country of ref document: EP

REN Ceased due to non-payment of the annual fee